Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Maitra PK, Lobo Z. Pyruvate kinase mutants of Saccharomyces cerevisiae: biochemical and genetic characterisation. Mol. Gen. Genet. 152: 193-200, 1977. PubMed: 327275, RefMaitra PK, Lobo Z. Yeast pyruvate kinase: a mutant from catalytically insensitive to fructose 1,6-bisphosphate. Eur. J. Biochem. 78: 353-360, 1977. PubMed: 21079, (pyk1-5 is allelic with cdc19.) Maitra PK, Lobo Z. Pyruvate kinase mutants of Saccharomyces cerevisiae: biochemical and genetic characterisation. Mol. Gen. Genet. 152: 193-200, 1977. PubMed: 327275
Maitra PK, Lobo Z. Yeast pyruvate kinase: a mutant from catalytically insensitive to fructose 1,6-bisphosphate. Eur. J. Biochem. 78: 353-360, 1977. PubMed: 21079
pyk1-5 is allelic with cdc19.
Maitra PK, Lobo Z. Pyruvate kinase mutants of Saccharomyces cerevisiae: biochemical and genetic characterisation. Mol. Gen. Genet. 152: 193-200, 1977. PubMed: 327275
Maitra PK, Lobo Z. Yeast pyruvate kinase: a mutant from catalytically insensitive to fructose 1,6-bisphosphate. Eur. J. Biochem. 78: 353-360, 1977. PubMed: 21079
pyk1-5 is allelic with cdc19.
